title: [Value of dynamic contrast-enhanced MRI in assessment of early response to neoadjuvant chemotherapy in breast cancer].
authors.affiliation: Department of Diagnostic Radiology, Cancer Hospital, Fudan University, Shanghai 200032, China.
authors.forename: Xiao-hong
authors.initials: XH
authors.lastname: Wang
authors.forename: Wei-jun
authors.initials: WJ
authors.lastname: Peng
authors.forename: Chao
authors.initials: C
authors.lastname: Xin
authors.forename: Hong-na
authors.initials: HN
authors.lastname: Tan
authors.forename: Ya-jia
authors.initials: YJ
authors.lastname: Gu
authors.forename: Feng
authors.initials: F
authors.lastname: Tang
authors.forename: Jian
authors.initials: J
authors.lastname: Mao
mesh_terms: D000328:Adult; D000368:Aged; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D001943:Breast Neoplasms / Q000188:drug therapy* / Q000473:pathology; D016190:Carboplatin / Q000008:administration & dosage; D018270:Carcinoma, Ductal, Breast / Q000188:drug therapy* / Q000473:pathology; D017024:Chemotherapy, Adjuvant; D003287:Contrast Media; D005260:Female; D006801:Humans; D008279:Magnetic Resonance Imaging / Q000379:methods*; D008875:Middle Aged; D020360:Neoadjuvant Therapy; D009367:Neoplasm Staging; D018365:Neoplasm, Residual; D017239:Paclitaxel / Q000008:administration & dosage
chemical_list: D003287:Contrast Media; D016190:Carboplatin; D017239:Paclitaxel